EVT beats medical management up to 96 hours after stroke

​

Endovascular treatment may be better late than never for stroke patients who miss the standard 24-hour treatment window,  according to a study published November 17 in Radiology. 

A group from eight Chinese stroke centers found that almost half of patients who underwent endovascular thrombectomy (EVT) versus best medical management for large vessel occlusion up to 96 hours after onset achieved functional independence. 

"Despite advances in imaging-based selection, the efficacy and safety of EVT in patients presenting greater than 24 hours to 96 hours after symptom onset remain unclear, particularly regarding functional outcomes and hemorrhagic risk," noted lead authors Tingyu Yi, MD, of Fujian Medical University in Zhangzhou, and Lan Hong, MD, of Fudan University in Shanghai, and colleagues. 

EVT is a standard treatment for acute ischemic stroke caused by intracranial large vessel occlusion. Initially, the time window for EVT was limited to within six hours after symptom onset, but was then extended up to 24 hours in selected patients after clinical trials showed it was effective in patients with salvageable tissue identified on imaging, the authors explained. Still, patients may present beyond the established 24-hour treatment window, they added. 

They included 205 patients (mean age, 67 years old) who underwent EVT and 103 who received best medical management (BMM) after presenting 24 to 96 hours after onset. The primary outcome was functional independence (a modified Rankin Scale score of 0 to 2) at 90 days. 

According to the results, functional independence at 90 days occurred in 50.7% of EVT patients versus 28.2% of BMM patients. After multivariable adjustment, the odds ratio for functional independence with EVT was 3.8 (p

"Endovascular treatment was associated with improved 90-day functional independence in patients with anterior circulation large vessel occlusion presenting 24–96 hours after onset, without clear increases in mortality or symptomatic intracranial hemorrhage," the group wrote. 

The findings support further evaluation of EVT in carefully selected patients with late-window presentation and should be confirmed in randomized trials, the group concluded. 

In an accompanying editorial, Eric Russell, MD, of Northwestern University, noted that the findings don’t diminish the urgency of rapid stroke identification and treatment. 

"Although these results support the adage 'better late than never' regarding many patients who will benefit from EVT in ever-later time windows, it should be stressed that these findings do not diminish the importance of rapid identification of stroke and achieving the shortest time from presentation to treatment possible," Russell noted. 

While EVT benefit may persist in selected patients presenting at 24 to 96 hours, the likelihood of favorable outcome becomes less certain with increasing delay, he wrote. 

The full study is available here. 

 

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.